| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/21/1988 | WO1988002632A1 Combinations of tumor necrosis factors and anti-inflammatory agents and methods for treating malignant and non-malignant diseases |
| 04/21/1988 | WO1988002631A1 IgE-INDUCED REGULANT (EIR) COMPOSITIONS |
| 04/21/1988 | WO1988002600A1 Enzyme-containing bactericidal composition, and dental and wound treatment preparations comprising this composition |
| 04/21/1988 | WO1988002594A2 Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereof |
| 04/20/1988 | EP0264250A2 Process for transforming a human insulin precursor to human insulin |
| 04/20/1988 | EP0264138A2 Novel compound DC-102 and process for production thereof |
| 04/20/1988 | EP0264106A2 5-Substituted amino-4-hydroxy-pentanoic acid derivatives and their use |
| 04/20/1988 | EP0264060A2 Anticoagulating substance and preparation process thereof |
| 04/20/1988 | EP0264017A2 Pharmaceutical compositions having healing activity |
| 04/20/1988 | EP0263933A1 A cDNA coding for carcinoembryonic antigen |
| 04/20/1988 | EP0263847A1 Methods and compositions relating to regression-associated antigens |
| 04/20/1988 | EP0053135B1 Production of ifn-gamma |
| 04/20/1988 | CN87106876A Antibiotics |
| 04/19/1988 | US4739066 Intermediates for the preparation of condensed seven-membered ring compounds |
| 04/19/1988 | US4739039 Method for preparing antihemophilic factor (AHF) by cold precipitation and for improving solubility of recovered AHF product |
| 04/19/1988 | US4738955 Polysulfates |
| 04/19/1988 | US4738952 Substitute for human blood and a method of making the same |
| 04/19/1988 | US4738845 Viricides, antitumor agents |
| 04/19/1988 | US4738844 Antivcral, antitumor, immunomodulatory agents |
| 04/19/1988 | US4738803 Enzyme inhibitors |
| 04/14/1988 | DE3633651A1 Use of fractions of thymus and spleen extracts for the treatment of psoriasis |
| 04/13/1988 | EP0263802A1 Kit of material containing a polypeptide of pancreatic islet amyloid and/or antibodies directed against said polypeptide, and use of said kit of material |
| 04/13/1988 | EP0263655A2 Novel peptides having antiallergic activity |
| 04/13/1988 | EP0263608A2 Protein having anticoagulant and antimetastatic properties |
| 04/13/1988 | EP0263529A1 Factor IX-derived peptides |
| 04/13/1988 | EP0263521A2 Gonadoliberine analogues with improved solubility, process for their preparation, agents containing them and their use |
| 04/13/1988 | EP0263506A2 Anticonvulsant composition containing amino acid derivative and use of said amino acid derivative |
| 04/13/1988 | EP0263502A2 Oligopeptide antibiotics |
| 04/13/1988 | EP0263490A2 Sustained-release particulate preparation and process for preparing the same |
| 04/13/1988 | EP0263417A1 Use of hyaluronidase |
| 04/13/1988 | EP0263214A1 Tetrapeptide methyl ketone inhibitors of viral proteases |
| 04/13/1988 | EP0263174A1 Increased vascular perfusion following administration of lipids |
| 04/13/1988 | EP0263172A1 Protein analogues of tissue plasminogen activator. |
| 04/13/1988 | EP0263135A1 Antiparatypical antibodies, their use for detecting and treating auto-immune diseases |
| 04/13/1988 | EP0263102A1 A cDNA MOLECULE CODING FOR THE EXPRESSION OF AN INTERFERON $g(a) TYPE POLYPEPTIDE, A BACTERIAL OR CELLULAR HOST TRANSFORMED WITH SUCH MOLECULE AND A POLYPEPTIDE SHOWING INTERFERON ACTIVITY PREPARED BY SUCH HOST |
| 04/12/1988 | US4737580 Platelet related growth regulator |
| 04/12/1988 | US4737578 Human inhibin |
| 04/12/1988 | US4737487 VIP type peptides |
| 04/12/1988 | US4737462 Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β |
| 04/12/1988 | US4737455 Analytical utilization of phagocyte cell lines |
| 04/12/1988 | CA1235118A1 Assay for qualitatively and/or quantitatively measuring hlh or hcg body fluids and reagents therefor |
| 04/07/1988 | WO1988002407A1 Recombinant dna clone encoding laminin receptor |
| 04/07/1988 | WO1988002401A1 Recombinant pseudomanas exotoxin: construction of an active immunotoxin with low side effects |
| 04/07/1988 | WO1988002374A2 Renin inhibitory peptides having novel c-terminal moieties |
| 04/07/1988 | WO1988002372A1 A cDNA CLONE FOR HUMAN TYROSINASE |
| 04/07/1988 | WO1988002261A1 Use of hyaluronidase |
| 04/07/1988 | WO1988000204A3 Polypeptide competitor for immunoglobulin e |
| 04/07/1988 | WO1987006617A3 Detection of a unique chlamydia strain associated with acute respiratory disease |
| 04/06/1988 | EP0263072A2 Novel lymphokine related peptides |
| 04/06/1988 | EP0262802A2 Medicament for the treatment or improvement of rheumatoid arthritis or systemic lupus erythematosus |
| 04/06/1988 | EP0262710A1 Use of a peptide for the preparation of compositions for the alleviation, treatment and diagnosis of autoimmune diseases, especially arthritic conditions, compounds related to said peptide, micro-organisms expressing said peptide or a compound related to said peptide, as well as pharmaceutical and diagnostic compositions and test kits |
| 04/06/1988 | EP0262696A2 Brain-specific drug delivery |
| 04/06/1988 | EP0262583A1 Parenteral depot preparations containing a calcium acetate-glycerol adduct for regulatory peptides |
| 04/06/1988 | EP0262571A2 Monoclonal antibodies against IFN-omega, process for preparing them and their use in the purification and detection of IFN-omega |
| 04/06/1988 | EP0262552A1 Pharmaceutical preparation for the treatment of hypertension |
| 04/06/1988 | EP0262318A2 Renin-inhibiting amino acid derivatives |
| 04/06/1988 | EP0262178A1 Amino acid chelated compositions for delivery to specific biological tissue sites. |
| 04/05/1988 | USRE32637 Antigrowth agent, viricide |
| 04/05/1988 | US4736066 Intermediate for substituted peptide compounds |
| 04/05/1988 | US4736024 Process for preparing salt of hyaluronic acid with a pharmaceutically active substance |
| 04/05/1988 | US4736023 DNA encoding human CGRP |
| 04/05/1988 | US4736022 Isolation of unreduced oligosaccharides |
| 04/05/1988 | US4736020 Ion exchange chromatography |
| 04/05/1988 | US4736018 Blood coagulation inhibiting proteins, processes for preparing them and their uses |
| 04/05/1988 | US4735933 Hypotensive |
| 04/05/1988 | US4735796 Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
| 04/05/1988 | CA1234801A1 Collagen membranes for medical use |
| 04/05/1988 | CA1234754A1 Agent and product for the diagnosis and treatment of tumors and for the treatment of weaknesses of the cellular and humoral immune defense |
| 03/30/1988 | EP0261798A2 Fertility control |
| 03/30/1988 | EP0261671A2 Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects |
| 03/30/1988 | EP0261599A2 Compositions suitable for human topical application including a growth factor and/or related materials |
| 03/30/1988 | EP0261592A1 Gene coding for human colony-stimulating factors |
| 03/30/1988 | EP0261239A1 Fsh-releasing peptide. |
| 03/29/1988 | US4734491 DNA sequences encoding hybrid lymphoblastoid-leukocyte human interferons |
| 03/29/1988 | US4734420 Anti-hypertensive agents |
| 03/29/1988 | US4734410 Lactam derivatives and their use as hypotensive agents |
| 03/29/1988 | US4734400 Bronchodilation without cardiovascular side effects |
| 03/29/1988 | US4734399 Growth hormone releasing factor analogs |
| 03/29/1988 | US4734398 Follicular regulating protein |
| 03/29/1988 | US4734362 Process for purifying recombinant proteins, and products thereof |
| 03/29/1988 | US4734286 Crosslinked poly β-alanine and compositions containing the same |
| 03/29/1988 | US4734279 Synergistic |
| 03/29/1988 | CA1234565A1 Heptadecapeptide |
| 03/24/1988 | WO1988002028A1 Monoclonal antibodies and their use |
| 03/24/1988 | WO1988002005A1 Insulin precursors |
| 03/24/1988 | WO1988001875A1 Immunomodulation |
| 03/24/1988 | WO1988001872A1 Method and substrate composition for treating atherosclerosis |
| 03/24/1988 | WO1988001869A1 Inhibition of protein kinase c by long-chain bases |
| 03/24/1988 | WO1987005909A3 Renin inhibitors having a lactam pseudo dipeptide |
| 03/23/1988 | EP0261016A1 Lipase and lipasic extracts, process of preparation and therapeutic use |
| 03/23/1988 | EP0260918A2 Megakaryocyte stimulatory factor |
| 03/23/1988 | EP0260880A2 Turning on of cytotoxicity |
| 03/23/1988 | EP0260796A1 Compositions of neocarzinostatin derivative for oral administration |
| 03/23/1988 | EP0260757A1 Recombinant DNA molecule; a process for producing human endothelial plasminogen activator inhibitor (PAI) or a mutant thereof; pharmaceutical composition; transformed host cells |
| 03/23/1988 | EP0260708A2 Tumor egress factor and processes for producing the same |
| 03/23/1988 | EP0260691A2 Immunotherapy for aids patients |
| 03/23/1988 | EP0260497A2 Lectin like protein substance having anti-tumor action |
| 03/23/1988 | EP0260350A1 Oxidation-resistant interferon-beta muteins and their production; formulations containing such muteins |
| 03/23/1988 | EP0260277A1 Method for the extraction of a vitamin-k-dependent carboxylase complex and the use thereof |
| 03/23/1988 | EP0201559A4 A method for preventing or alleviating skin irritation using a formulation containing superoxide dismutase. |